Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
21.20
+0.36 (1.73%)
At close: Sep 16, 2026, 4:00 PM EDT
21.20
0.00 (0.00%)
After-hours: Sep 16, 2026, 4:04 PM EDT
Innoviva Employees
Innoviva had 159 employees as of December 31, 2025. The number of employees increased by 32 or 25.20% compared to the previous year.
Employees
159
Change (1Y)
32
Growth (1Y)
25.20%
Revenue / Employee
$2,767,283
Profits / Employee
$2,246,767
Market Cap
1.53B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Immunocore Holdings | 524 |
| Intellia Therapeutics | 377 |
| Syndax Pharmaceuticals | 298 |
| Inhibrx Biosciences | 110 |
| AnaptysBio | 104 |
| Bicara Therapeutics | 103 |
| Avalyn Pharma | 55 |
INVA News
- 2 days ago - Innoviva Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 6 days ago - Innoviva Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 14 days ago - Innoviva to Participate in Upcoming Investor Conferences - Business Wire
- 4 weeks ago - Innoviva management to meet virtually with Cantor Fitzgerald - TheFly
- 5 weeks ago - Innoviva Specialty Therapeutics' Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award - Business Wire
- 5 weeks ago - Innoviva price target lowered to $34 from $36 at Cantor Fitzgerald - TheFly
- 6 weeks ago - Innoviva reports Q2 EPS ($1.14), consensus 49c - TheFly
- 6 weeks ago - Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress - Business Wire